Funded Tech Companies

Akero Therapeutics

Headquartered in Cambridge, Akero Therapeutics raised its funding from BVF Partners, Boxer Capital and venBio.

Company Overview

Contact Information

Company Background Information

Overview

Akero Therapeutics (Nasdaq: AKRO) is committed to providing meaningful treatment options for people with serious metabolic diseases like non-alcoholic steatohepatitis (NASH), a disease marked by inflammation in the liver and liver cell damage resulting in fibrosis, cirrhosis, liver failure and death.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

6/19/2019

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Andrew Cheng

        

Chief Operating Officer

Jonathan Young

        

Chief Scientific Officer

Timothy Rolph

        

VP - Bus. Development

Kitty Yale

        

Company Investors

• BVF Partners
• Boxer Capital
• venBio (Aaron Royston)
• Atlas Venture (Kevin Bitterman)
• Rock Springs Capital
• Versant Ventures (Graham Walmsley)
• Apple Tree Partners (Aaron Kantoff)
• LifeSci Venture Partners
• Cormorant Asset Management
• Redmile Group
• Janus Henderson Investors

Browse more funded tech companies:

Akermin | Akeso Biomedical

Share this article

About Our VC Deals Database

The company data above is provided by VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary